What is the appropriate dose of trimethoprim‑sulfamethoxazole (Bactrim) for a 5‑year‑old child with an uncomplicated urinary‑tract infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bactrim Dosing for 5-Year-Old with UTI

For a 5-year-old child with an uncomplicated UTI, administer trimethoprim-sulfamethoxazole (Bactrim) at a dose of 6–12 mg/kg/day of the trimethoprim component divided into 2 doses every 12 hours for 7–14 days 1, 2.

Specific Dosing Calculation

The American Academy of Pediatrics guideline for pediatric UTI treatment specifies:

  • Trimethoprim component: 6–12 mg/kg per day
  • Sulfamethoxazole component: 30–60 mg/kg per day
  • Frequency: Divided into 2 doses given every 12 hours 1

The FDA-approved dosing from the Bactrim label confirms this regimen: 40 mg/kg sulfamethoxazole and 8 mg/kg trimethoprim per 24 hours, given in two divided doses every 12 hours 2.

Practical Example for a 5-Year-Old

For a typical 5-year-old weighing approximately 18–20 kg:

  • Using 8 mg/kg trimethoprim: 144–160 mg trimethoprim daily
  • This translates to approximately 1 single-strength tablet (80 mg TMP/400 mg SMX) twice daily
  • Or ½ double-strength tablet twice daily

Treatment Duration

Treat for 7–14 days 1. The AAP guidelines attempted to identify a single preferred duration but found insufficient data comparing 7,10, and 14 days directly. However, they clearly established that 1–3 day courses are inferior, making 7 days the minimum acceptable duration 1.

Critical Caveats Before Prescribing

Local Resistance Patterns Matter

Do not use trimethoprim-sulfamethoxazole empirically if local resistance rates exceed 20% 3. The IDSA guideline for adult cystitis established this threshold based on clinical, in vitro, and mathematical modeling studies. While this guideline addresses adults, the principle applies to pediatric prescribing—you must know your local susceptibility patterns 1.

When NOT to Use Bactrim

  • Febrile UTI/suspected pyelonephritis: Bactrim may be used, but only if local resistance is low. For febrile UTIs, ensure the antibiotic achieves adequate parenchymal concentrations 1
  • Age < 2 months: Bactrim is contraindicated 2
  • Known sulfa allergy
  • Severe renal impairment: Requires dose adjustment 2

Geographic Variability

The AAP guidelines explicitly warn that "there is substantial geographic variability" in resistance patterns for trimethoprim-sulfamethoxazole that "needs to be taken into account during selection of an antimicrobial agent before sensitivity results are available" 1. Recent data show trimethoprim-sulfamethoxazole resistance has increased significantly in many regions 4, 5.

Alternative First-Line Options

If Bactrim is inappropriate due to resistance or allergy:

  • Cephalexin: 50–100 mg/kg/day in 4 divided doses 1
  • Cefixime: 8 mg/kg/day in 1 dose 1
  • Amoxicillin-clavulanate: 20–40 mg/kg/day in 3 doses 1

Nitrofurantoin should NOT be used for febrile UTIs in children, as it does not achieve adequate parenchymal or serum concentrations to treat pyelonephritis 1.

Clinical Decision Algorithm

  1. Confirm diagnosis: Ensure ≥50,000 CFU/mL of single uropathogen 1
  2. Assess severity: Is the child febrile, toxic-appearing, or unable to tolerate oral intake?
    • If yes → Consider parenteral therapy initially (ceftriaxone 75 mg/kg every 24h) 1
    • If no → Proceed with oral therapy
  3. Check local resistance data: Is TMP-SMX resistance <20% in your community?
    • If yes → TMP-SMX is appropriate
    • If no or unknown → Choose alternative (cephalosporin preferred)
  4. Prescribe appropriate duration: 7–14 days (not 3 days as in adults)
  5. Obtain culture and adjust: Modify therapy based on susceptibility results

Related Questions

What dose of trimethoprim‑sulfamethoxazole suspension should be given to a 21.6 kg child for a urinary tract infection?
What is the appropriate dose of trimethoprim‑sulfamethoxazole (Bactrim) for a 3‑year‑old child weighing 12.75 kg with an uncomplicated urinary tract infection?
For a woman with recurrent urinary tract infections, should Bactrim (trimethoprim‑sulfamethoxazole) be prescribed for three days or five days?
Is Bactrim (trimethoprim‑sulfamethoxazole) appropriate for treating an uncomplicated urinary tract infection in a male patient?
Should I change the antibiotic therapy for a female patient with a urinary tract infection who was initially treated with trimethoprim‑sulfamethoxazole (Bactrim) and now presents to the emergency department with worsening symptoms despite normal laboratory results?
Can a pregnant woman safely take a bath?
What is the appropriate pharmacologic treatment for sinus tachycardia caused by medicinal cannabis use, and are antibiotics indicated?
What empiric antimicrobial regimen should be started for a rheumatoid arthritis patient who is not currently on antibiotics and likely has a bone infection, ensuring coverage for MRSA and Gram‑negative bacilli with good bone penetration?
How should a movement disorder induced by atypical antipsychotics be assessed and managed?
Do you recommend naltrexone for a 14‑year‑old with pornography addiction, and what other medications can be prescribed?
Can an acute myocardial infarction (MI) or a cardiac arrhythmia cause sudden loss of consciousness (decreased level of consciousness)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.